Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period
Research Grant
Administered By
Duke Clinical Research Institute
Awarded By
Food and Drug Administration
Start Date
September 22, 2022
End Date
June 30, 2024
Administered By
Duke Clinical Research Institute
Awarded By
Food and Drug Administration
Start Date
September 22, 2022
End Date
June 30, 2024